Decoy Therapeutics
DCOY----
Decoy Therapeutics (DCOY)
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Decoy Therapeutics Analyst Rating
View MoreForecast & Rating
Jan 23, 2026Price forecast
$30.00495.24%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 2 hours ago
Decoy Therapeutics announces special shareholder meeting
- benzinga_article · Jul 16 at 07:05 AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- PUBT · Jul 15 at 04:15 PM
Decoy Therapeutics holds annual shareholder meeting
- StockTitan · Jul 15 at 12:24 AM
Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors | DCOY Stock News
- Price Alert · Jul 10 at 01:52 PM
U.S. stock market midday update: Decoy Therapeutics down 8.54%, volume increased, sector volatility intensified
- Price Alert · Jul 9 at 01:47 PM
U.S. stock market midday update: Decoy Therapeutics up 13.04%, influx of funds boosts volatility
